Zobrazeno 1 - 10
of 696
pro vyhledávání: '"BROWN, L.C."'
Autor:
Sun, G., Fuller, H., Fenton, H., Race, Amanda D., Downing, A., Williams, E.A., Rees, C.J., Brown, L.C., Loadman, Paul, Hull, M.A.
Yes
Urinary prostaglandin (PG) E metabolite (PGE-M) and 11-dehydro (d)-thromboxane (TX) B2 are biomarkers of cyclooxygenase-dependent prostanoid synthesis. We investigated (1) the effect of aspirin 300 mg daily and eicosapentaenoic acid (EPA) 20
Urinary prostaglandin (PG) E metabolite (PGE-M) and 11-dehydro (d)-thromboxane (TX) B2 are biomarkers of cyclooxygenase-dependent prostanoid synthesis. We investigated (1) the effect of aspirin 300 mg daily and eicosapentaenoic acid (EPA) 20
Externí odkaz:
http://hdl.handle.net/10454/19689
Autor:
Davies, J.R., Mell, T., Fuller, H., Harland, M., Saleh, R.N.M., Race, Amanda D., Rees, C.J., Brown, L.C., Loadman, Paul, Downing, A., Minihane, A.M., Williams, E.A., Hull, M.A.
Yes
Aspirin and eicosapentaenoic acid (EPA) reduce colorectal adenomatous polyp risk and affect synthesis of oxylipins including prostaglandin E2. We investigated whether 35 single nucleotide polymorphisms (SNPs) in oxylipin metabolism genes suc
Aspirin and eicosapentaenoic acid (EPA) reduce colorectal adenomatous polyp risk and affect synthesis of oxylipins including prostaglandin E2. We investigated whether 35 single nucleotide polymorphisms (SNPs) in oxylipin metabolism genes suc
Externí odkaz:
http://hdl.handle.net/10454/19688
Autor:
Downing, A., Fenton, H., Nickerson, C., Loadman, Paul, Williams, E.A., Rees, C.J., Brown, L.C., Morris, E.J.A., Hull, M.A.
Yes
The seAFOod polyp prevention trial was a randomised, placebo-controlled, 2 × 2 factorial trial of aspirin 300 mg and eicosapentaenoic acid (EPA) 2000 mg daily in individuals who had a screening colonoscopy in the English Bowel Cancer Screen
The seAFOod polyp prevention trial was a randomised, placebo-controlled, 2 × 2 factorial trial of aspirin 300 mg and eicosapentaenoic acid (EPA) 2000 mg daily in individuals who had a screening colonoscopy in the English Bowel Cancer Screen
Externí odkaz:
http://hdl.handle.net/10454/19635
Autor:
Fuller, H., Race, Amanda D., Fenton, H., Burke, L., Downing, A., Williams, E.A., Rees, C.J., Brown, L.C., Loadman, Paul, Hull, M.A.
Yes
Aspirin and eicosapentaenoic acid (EPA) have colorectal polyp prevention activity, alone and in combination. This study measured levels of plasma and rectal mucosal oxylipins in participants of the seAFOod 2 × 2 factorial, randomised, place
Aspirin and eicosapentaenoic acid (EPA) have colorectal polyp prevention activity, alone and in combination. This study measured levels of plasma and rectal mucosal oxylipins in participants of the seAFOod 2 × 2 factorial, randomised, place
Externí odkaz:
http://hdl.handle.net/10454/19605
Autor:
Abdel-Aty, H. ∗, †, ‡, O'Shea, L. ‡, Amos, C. ‡, Brown, L.C. ‡, Grist, E. §, Attard, G. §, Clarke, N. ¶, Cross, W. ||, Parker, C. ∗, †, Parmar, M. ‡, As, N.vas ∗, †, James, N. ∗, †
Publikováno v:
In Clinical Oncology October 2023 35(10):e628-e635
Autor:
Luen, S.J., Viale, G., Nik-Zainal, S., Savas, P., Kammler, R., Dell’Orto, P., Biasi, O., Degasperi, A., Brown, L.C., Láng, I., MacGrogan, G., Tondini, C., Bellet, M., Villa, F., Bernardo, A., Ciruelos, E., Karlsson, P., Neven, P., Climent, M., Müller, B., Joshum, W., Bonnefoi, H., Martino, S., Davidson, N.E., Geyer, C., Chia, S.K., Ingle, J.N., Coleman, R., Solbach, C., Thürlimann, B., Colleoni, M., Coates, A.S., Goldhirsch, A., Fleming, G.F., Francis, P.A., Speed, T.P., Regan, M.M., Loi, S.
Publikováno v:
In Annals of Oncology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Cold Regions Science and Technology December 2015 120:115-126
Autor:
Gillessen, S., Murphy, L.R., James, N.D., Sachdeva, A., Attard, G., Jones, R.J., Adler, A., El-Taji, O., Varughese, M., Gale, J., Brown, S.J., Srihari, N.N., Millman, R., Matheson, D., Amos, C.L., Murphy, C., McAlpine, C., Parmar, M.K., Brown, L.C., Clarke, N.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1258-S1259